MinervaX

Clinical-stage biotechnology company developing a Group B Streptococcus (GBS) vaccine to prevent life-threatening infections in newborns through maternal immunization.

Location
Copenhagen, Denmark
Founded
2010
Investors
1
Categories
vaccines, infectious-disease, maternal-health, biotech, neonatal

Investors

NameLocationTypeStagesPortfolio
Adjuvant CapitalWashington, DC, USAbiotech-focused
seedseries-a+3
16